Biotie floats in US
This article was originally published in Scrip
Executive Summary
Nordic firm Biotie Therapies, a company focused on products for neurodegenerative and psychiatric disorders, has listed on a US stock market in preparation for its Phase III Parkinson's disease study, which has been granted a green light by the FDA.